(Q51470458)

English

Postmarketing surveillance study of the efficacy and tolerability of pioglitazone in insulin-resistant patients with type 2 diabetes mellitus in general practice.

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17536886

Postmarketing surveillance study of the efficacy and tolerability of pioglitazone in insulin-resistant patients with type 2 diabetes mellitus in general practice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17536886

type 2 diabetes

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Christof Schöfl

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17536886

Georg Lübben

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17536886

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17536886

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17536886

23

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17536886

11

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17536886

725-734

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17536886

Pioglitazone: a review of Japanese clinical studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety profile of pioglitazone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic efficacy and safety of once-daily pioglitazone monotherapy in patients with type 2 diabetes: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Desktop Guide to Type 1 (Insulin-dependent) Diabetes Mellitus: European Diabetes Policy Group 1998, International Diabetes Federation, European Region

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revealing the cost of Type II diabetes in Europe.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The continuing epidemics of obesity and diabetes in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic costs of diabetes in the US in 2002.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17536886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200323110-00005

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17536886

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17536886

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51470458&oldid=1539395080"